SCHEMBL24487270

SCHEMBL24487270

CCN(CC)CNC(=S)OCc1cc(=O)oc2ccc(CNC(=O)ON3C(=O)CCC3=O)cc12

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 11/20 0.35
▸ TSHR P16473 8/20 0.35
▸ NPSR1 Q6W5P4 5/20 0.35
▸ HSD17B10 Q99714 5/20 0.34
▸ KDM4E B2RXH2 8/20 0.33
▸ LMNA P02545 5/20 0.33
▸ SMN1; SMN2 Q16637 5/20 0.33
▸ HPGD P15428 5/20 0.33
▸ MEN1 O00255 3/20 0.33
▸ KMT2A Q03164 3/20 0.33
▸ MAPT P10636 3/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ GLA P06280 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ USP2 O75604 2/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24486801 0.87 ALDH1A1 (0.38) ALDH1A1TSHRNPSR1HSD17B10KDM4E
SCHEMBL24486820 0.81 CYP2D6 (0.41) ALDH1A1TSHRNPSR1HSD17B10KDM4E
SCHEMBL24487264 0.81 KMT2A (0.32) ALDH1A1TSHRNPSR1HSD17B10KDM4E
SCHEMBL24486871 0.80 ALDH1A1 (0.34) ALDH1A1TSHRNPSR1HSD17B10KDM4E
SCHEMBL24487168 0.79 KDM4E (0.36) ALDH1A1HSD17B10KDM4ELMNASMN1; SMN2
SCHEMBL24487265 0.78 ALDH1A1 (0.38) ALDH1A1HSD17B10KDM4ELMNASMN1; SMN2
SCHEMBL24486956 0.76 ALDH1A1 (0.33) ALDH1A1TSHRNPSR1HSD17B10KDM4E
SCHEMBL24486869 0.75 ALDH1A1 (0.36) ALDH1A1TSHRNPSR1HSD17B10KDM4E
SCHEMBL24486993 0.74 ALDH1A1 (0.35) ALDH1A1TSHRNPSR1HSD17B10KDM4E
SCHEMBL24487003 0.73 ALDH1A1 (0.34) ALDH1A1TSHRNPSR1HSD17B10KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11352325-B2 Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals WATERS TECHNOLOGIES CORPORATION (US) 2022-06-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11352325-B2 Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals FUT5, FUT6, ST3GAL3 ALDH1A1 1650/4885TSHR 973/4885NPSR1 282/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback